Assignee
SWEDISH ORPHAN BIOVITRUM AB PUBL
SE·10 granted patents·11 pending applications·16 citations·filing 2012–2024
Top patents by PatentIndex Score
21 records- 0183US10206975B2Polypeptides binding to human complement C5SWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2017·Granted Feb 19, 2019·3 cites·22 claims
- 0282US9808502B2Polypeptides binding to human complement C5SWEDISH ORPHAN BIOVITRUM AB (PUBL)·Filed 2013·Granted Nov 7, 2017·5 cites·35 claims
- 0378US9994626B2Stable polypeptides binding to human complement C5SWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2014·Granted Jun 12, 2018·5 cites·14 claims
- 0474US2025066451A1Il-ir-i binding polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2024·Application pending·0 cites
- 0572US9982243B2Modified sulfamidase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Granted May 29, 2018·3 cites·13 claims
- 0664US2026053893A1Anakinra for the treatment of post acute covid syndromeSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2023·Application pending·0 cites
- 0761US2021121571A1Methods of reducing aggregation of il-1raSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2020·Application pending·0 cites
- 0855US12116397B2IL-IR-I binding polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Granted Oct 15, 2024·0 cites·25 claims
- 0952US11730677B2Syringe assembly with ion-exchange materialSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Granted Aug 22, 2023·0 cites·15 claims
- 1051US2023114594A1New therapeutic use of anakinra for covid-19SWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2021·Application pending·0 cites
- 1149US10179162B2Citrate free pharmaceutical compositions comprising anakinraSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Granted Jan 15, 2019·0 cites·17 claims
- 1248US2015191714A1Formulations of recombinant human bile salt-stimulated lipaseSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2012·Application pending·0 cites
- 1340US11584778B2Fusion protein with half-life extending polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Granted Feb 21, 2023·0 cites·18 claims
- 1440US2018320152A1Modified sulfamidase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Application pending·0 cites
- 1539US11191903B2Syringe plunger rodSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Granted Dec 7, 2021·0 cites·18 claims
- 1637US11324807B2Compositions comprising anakinraSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2016·Granted May 10, 2022·0 cites·31 claims
- 1735US2023085602A1Pdac treatment regimenSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2021·Application pending·0 cites
- 1833US2015283215A1Method to increase the growth velocity of human infantsSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Application pending·0 cites
- 1933US2015297683A1Method to increase the absorption of unsaturated fatty acids by human infantsSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Application pending·0 cites
- 2031US2018264089A1Modified iduronate 2-sulfatase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2016·Application pending·0 cites
- 2127US2018258408A1Modified lysosomal protein and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SWEDISH ORPHAN BIOVITRUM AB PUBL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →